Literature DB >> 25466646

Effect of temperature shift on levels of acidic charge variants in IgG monoclonal antibodies in Chinese hamster ovary cell culture.

Shohei Kishishita1, Tomoko Nishikawa2, Yasuharu Shinoda2, Hiroaki Nagashima2, Hiroshi Okamoto2, Shinya Takuma2, Hideki Aoyagi3.   

Abstract

During the production of therapeutic monoclonal antibodies (mAbs), not only enhancement of mAb productivity but also control of quality attributes is critical. Charge variants, which are among the most important quality attributes, can substantially affect the in vitro and in vivo properties of mAbs. During process development for the production of mAbs in a Chinese hamster ovary cell line, we have observed that an improvement in mAb titer is accompanied by an increase in the content of acidic charge variants. Here, to help maintain comparability among mAbs, we aimed to identify the process parameters that controlled the content of acidic charge variants. First, we used a Plackett-Burman design to identify the effect of selected process parameters on the acidic charge variant content. Eight process parameters were selected by using a failure modes and effects analysis. Among these, temperature shift was identified from the Plackett-Burman design as the factor most influencing the acidic charge variant content. We then investigated in more detail the effects of shift temperature and temperature shift timing on this content. The content decreased with a shift to a lower temperature and with earlier timing of this temperature shift. Our observations suggest that Plackett-Burman designs are advantageous for preliminary screening of bioprocess parameters. We report here for the first time that temperature downshift is beneficial for effective control of the acidic peak variant content.
Copyright © 2014 The Society for Biotechnology, Japan. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acidic charge variants; Chinese hamster ovary cells; IgG monoclonal antibody; Plackett–Burman design; Temperature shift

Mesh:

Substances:

Year:  2014        PMID: 25466646     DOI: 10.1016/j.jbiosc.2014.10.028

Source DB:  PubMed          Journal:  J Biosci Bioeng        ISSN: 1347-4421            Impact factor:   2.894


  7 in total

1.  Systematic development of temperature shift strategies for Chinese hamster ovary cells based on short duration cultures and kinetic modeling.

Authors:  Jianlin Xu; Peifeng Tang; Andrew Yongky; Barry Drew; Michael C Borys; Shijie Liu; Zheng Jian Li
Journal:  MAbs       Date:  2018-10-02       Impact factor: 5.857

2.  Improving titer while maintaining quality of final formulated drug substance via optimization of CHO cell culture conditions in low-iron chemically defined media.

Authors:  Jianlin Xu; Matthew S Rehmann; Xuankuo Xu; Chao Huang; Jun Tian; Nan-Xin Qian; Zheng Jian Li
Journal:  MAbs       Date:  2018-02-20       Impact factor: 5.857

3.  Reduction of charge variants by CHO cell culture process optimization.

Authors:  Zhibing Weng; Jian Jin; ChunHua Shao; Huazhong Li
Journal:  Cytotechnology       Date:  2020-03-31       Impact factor: 2.058

Review 4.  Main Quality Attributes of Monoclonal Antibodies and Effect of Cell Culture Components

Authors:  Fatemeh Torkashvand; Behrouz Vaziri
Journal:  Iran Biomed J       Date:  2017-04-20

Review 5.  Advances in recombinant antibody manufacturing.

Authors:  Renate Kunert; David Reinhart
Journal:  Appl Microbiol Biotechnol       Date:  2016-03-03       Impact factor: 4.813

6.  Investigation of the interactions of critical scale-up parameters (pH, pO2 and pCO2) on CHO batch performance and critical quality attributes.

Authors:  Matthias Brunner; Jens Fricke; Paul Kroll; Christoph Herwig
Journal:  Bioprocess Biosyst Eng       Date:  2016-10-17       Impact factor: 3.210

7.  Cysteine in cell culture media induces acidic IgG1 species by disrupting the disulfide bond network.

Authors:  Elke Prade; Anne Zeck; Fabian Stiefel; Andreas Unsoeld; David Mentrup; Erik Arango Gutierrez; Ingo H Gorr
Journal:  Biotechnol Bioeng       Date:  2020-12-16       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.